Rezultati pretraživanja
  1. 15. ožu 2018.

    : Cantor Fitzgerald reiterates overweight and raises PT to $16. AURORA may complete enrollment by 4Q18.

  2. 27. ožu 2017.
  3. 21. pro 2017.
  4. , , ... and others that are coming. This is a great time (never thought) for treatment.

  5. 29. kol 2015.

    Stephen Zaruby (CEO) and Neil Solomons (CMO) open up about what's in store for Aurinia .

  6. Here at KidneyWeek2017. Exciting to see our data presented by others in the sessions here.

  7. 25. lip 2017.

    Churg-Strauss syndrome would be good candidate for Glickman's "other indication"

  8. 4. pro 2019.

    "Couldnt be any better" ph3 results for + patent protection for granted in the middle of 2019 = AUPH is a derisked asset for any BigPharma to gobble up for lupus nephritis. Buyout prices should be north of $30+

  9. 4. pro 2019.
  10. 20. tra 2017.

    despite your positive feedback on . There is a # of people who are bearish on the company and study design

  11. meets 48-week remission endpoints, achieving highest CR of any global study

  12. 27. ožu 2018.
  13. 15. svi 2017.

    NEA Management owns as well. Maybe Scott Gottlieb will also grant AA for .

  14. 15. svi 2017.

    and hold for Ph3 results or B/O. Barring unforeseen toxicity, at 40%+ CR, will be utilized for treating LN patients.

  15. 4. tra 2017.

    to present late breaker poster session at National Kidney Foundation spring meeting on April 20

  16. 15. kol 2016.

    Facing questions on patient deaths, shares crater in wake of lupus study via

  17. 17. pro 2019.

    Results showed that renal response was achieved by 40.8% of -treated patients compared with 22.5% of the placebo group.🌡

  18. Odgovor korisniku/ci

    Absolutely. Well done all but Brad you need to start using hashtags!!!

  19. 15. kol 2016.

    Aurinia lupus candidate hits PhII target, but deaths send stock down via

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.